<h1 id="rectal-cancer-contouring-summary">Rectal cancer Contouring summary</h1>
<h2 id="treatment-planning">Treatment Planning</h2>
<ul>
<li>CT Simulation</li>
<li>IV contrast may be used to delineate GTV and pelvic blood vessels</li>
<li>Supine with body immobilizaton or</li>
<li>Prone with use of a belly board for anterior displacement of bowel</li>
</ul>
<h2 id="target-volumes">Target Volumes</h2>
<ul>
<li>CTVA: always treated for rectal cancer: internal iliac, pre-sacral, and peri-rectal</li>
<li>CTVB: external iliac nodal region</li>
<li>CTVC: inguinal nodal region</li>
<li>For rectal cancer, in most cases, CTVA would be the only volume to receive elective RT</li>
<li>For certain presentations (e.g.Â extension into GU structures, extension to the peri-anal skin) one could consider adding the external iliac (CTVB) and even the inguinal regions (CTVC)</li>
</ul>
<h2 id="target-volumes-ctva">Target Volumes: CTVA</h2>
<ul>
<li>Inferior</li>
<li>At least 2 cm caudad to gross disease, including coverage of the entire mesorectum to the pelvic floor</li>
<li>Posterior and lateral</li>
<li>Lateral pelvic sidewall musculature or, where absent, the bone</li>
<li>Anterior
<ul>
<li>~1 cm into the posterior bladder and the posterior portion of the internal obturator vessels</li>
</ul></li>
<li>Superior
<ul>
<li>Primary: the rectosigmoid junction or 2 cm proximal to the superior extent of macroscopic disease</li>
<li>LN: where the common iliac vessels bifurcate into external/internal iliacs (approximate boney landmark: sacral promontory)</li>
</ul></li>
<li>PTV margin should be ~0.7 to 1.0 cm, except at skin.</li>
</ul>
